Clinical Trials Directory

Trials / Completed

CompletedNCT04403009

The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19

The Clinical Difference Between the Nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the Fatal Cases With Severe COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
20 Years – 100 Years
Healthy volunteers
Not accepted

Summary

To investigate the difference of the difference between the nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the fatal Patients .The cross sectional study was undertaken to compare the clinical information (laboratory and radiologic characteristics)of nonfatal participants and fatal cases. The investigators wish figure out the clinical character of the fatal participants. The result may help the physician to find the fatal patients with COVID-19 more easily. The fatal patients with COVID-19 could be treated early.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2020-02-01
Primary completion
2020-06-06
Completion
2020-06-20
First posted
2020-05-27
Last updated
2023-03-07

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04403009. Inclusion in this directory is not an endorsement.

The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 (NCT04403009) · Clinical Trials Directory